State laws determine whether pharmacists must or can choose to swap brand-name drugs for generics. These rules affect your costs, safety, and whether you even know you're getting a different pill.
learn moreMethotrexate and NSAIDs can dangerously raise methotrexate levels and harm kidney function. Learn who's at risk, which NSAIDs are safest, and how to prevent life-threatening toxicity.
learn moreOrphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, incentivizing development where profits are low. Learn how it works, how it compares to Europe, and why it's both vital and controversial.
learn moreSGLT2 inhibitors like Jardiance and Farxiga offer powerful heart and kidney protection for type 2 diabetes patients-but come with risks like yeast infections, ketoacidosis, and kidney stress. Know who benefits most and what to watch for.
learn morePatent litigation in generic drug markets is delaying affordable medicines, costing billions annually. Learn how the Hatch-Waxman Act, Orange Book listings, and pay-for-delay settlements are shaping access to generics.
learn moreLinezolid can cause a dangerous blood pressure spike if you eat tyramine-rich foods like aged cheese, cured meats, or red wine. Learn exactly what to avoid, what’s safe, and why you must wait 14 days after treatment.
learn moreTrimethoprim, a common antibiotic, can dangerously raise potassium levels - even in people with healthy kidneys. Learn who’s at risk, how fast it happens, and what safer alternatives exist.
learn moreStudies show that switching generics for narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and cyclosporine can affect blood levels and patient outcomes. Learn what the data says-and what you should do.
learn moreChoosing between overseas and domestic generic manufacturing involves more than cost. Learn how lead times, quality control, tariffs, and IP risks shape the best decision for your product and business.
learn moreThe FDA ensures generic drug safety through strict manufacturing rules, global inspections, and continuous monitoring. Every generic must prove it's bioequivalent to the brand-name version and meet the same quality standards - no exceptions.
learn more